RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Argatroban Safe and Promising as Monotherapy or Combined with Tissue Plasminogen Activator
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 1
SP 27
OP 28
DO 10.1177/155989771401017
UL http://mdc.sagepub.com/content/14/1/27.abstract
AB This article presents data from three clinical trials, and also discussed off-label use of argatroban for ischemic stroke. The results demonstrated positive clinical outcomes, indicating that argatroban appears to be safe and promising, both as monotherapy and in combination with intravenous tissue plasminogen activator (t-PA) for patients with ischemic stroke.